Melatonin does not reduce mortality in adult hospitalized patients with COVID-19: a multicenter retrospective observational study

In this multicenter retrospective observational study involving 58 562 adult patients hospitalized for COVID-19, melatonin use (N = 272) at a mean daily dose of 2.6 mg was not associated with reduced mortality.

Automated summary

This multicenter retrospective observational study involving 58,562 adult patients hospitalized for COVID-19 found that melatonin use at a mean daily dose of 2.6 mg was not associated with reduced mortality.